1. Home
  2. SNTI vs BLMZ Comparison

SNTI vs BLMZ Comparison

Compare SNTI & BLMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • BLMZ
  • Stock Information
  • Founded
  • SNTI 2016
  • BLMZ 2017
  • Country
  • SNTI United States
  • BLMZ Japan
  • Employees
  • SNTI N/A
  • BLMZ N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • BLMZ
  • Sector
  • SNTI Health Care
  • BLMZ
  • Exchange
  • SNTI Nasdaq
  • BLMZ NYSE
  • Market Cap
  • SNTI 14.1M
  • BLMZ 15.5M
  • IPO Year
  • SNTI N/A
  • BLMZ 2024
  • Fundamental
  • Price
  • SNTI $2.42
  • BLMZ $0.68
  • Analyst Decision
  • SNTI
  • BLMZ
  • Analyst Count
  • SNTI 0
  • BLMZ 0
  • Target Price
  • SNTI N/A
  • BLMZ N/A
  • AVG Volume (30 Days)
  • SNTI 18.4K
  • BLMZ 2.7M
  • Earning Date
  • SNTI 11-11-2024
  • BLMZ 11-15-2024
  • Dividend Yield
  • SNTI N/A
  • BLMZ N/A
  • EPS Growth
  • SNTI N/A
  • BLMZ N/A
  • EPS
  • SNTI N/A
  • BLMZ N/A
  • Revenue
  • SNTI $338,000.00
  • BLMZ $1,246,643.00
  • Revenue This Year
  • SNTI $254.47
  • BLMZ N/A
  • Revenue Next Year
  • SNTI $169.66
  • BLMZ N/A
  • P/E Ratio
  • SNTI N/A
  • BLMZ N/A
  • Revenue Growth
  • SNTI N/A
  • BLMZ 29.63
  • 52 Week Low
  • SNTI $1.52
  • BLMZ $0.68
  • 52 Week High
  • SNTI $8.48
  • BLMZ $4.30
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 44.72
  • BLMZ N/A
  • Support Level
  • SNTI $2.05
  • BLMZ N/A
  • Resistance Level
  • SNTI $2.46
  • BLMZ N/A
  • Average True Range (ATR)
  • SNTI 0.24
  • BLMZ 0.00
  • MACD
  • SNTI -0.07
  • BLMZ 0.00
  • Stochastic Oscillator
  • SNTI 29.44
  • BLMZ 0.00

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About BLMZ BLOOMZ INC

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

Share on Social Networks: